Your browser doesn't support javascript.
loading
Five cases of malignant melanoma during fingolimod treatment in Dutch patients with MS.
Killestein, Joep; Leurs, Cyra E; Hoogervorst, Erwin L J; van Eijk, Jeroen; Mostert, Jop P; van den Eertwegh, Alfons J M; Uitdehaag, Bernard M J.
Affiliation
  • Killestein J; From the Department of Neurology, Amsterdam Neuroscience, VUmc MS Centre Amsterdam (J.K., C.E.L., B.M.J.U.) and Department of Medical Oncology (A.J.M.v.d.E.), VU University Medical Centre; Department of Neurology (E.L.J.H.), St. Antonius Hospital Utrecht; Department of Neurology (J.v.E.), Jeroen Bos
  • Leurs CE; From the Department of Neurology, Amsterdam Neuroscience, VUmc MS Centre Amsterdam (J.K., C.E.L., B.M.J.U.) and Department of Medical Oncology (A.J.M.v.d.E.), VU University Medical Centre; Department of Neurology (E.L.J.H.), St. Antonius Hospital Utrecht; Department of Neurology (J.v.E.), Jeroen Bos
  • Hoogervorst ELJ; From the Department of Neurology, Amsterdam Neuroscience, VUmc MS Centre Amsterdam (J.K., C.E.L., B.M.J.U.) and Department of Medical Oncology (A.J.M.v.d.E.), VU University Medical Centre; Department of Neurology (E.L.J.H.), St. Antonius Hospital Utrecht; Department of Neurology (J.v.E.), Jeroen Bos
  • van Eijk J; From the Department of Neurology, Amsterdam Neuroscience, VUmc MS Centre Amsterdam (J.K., C.E.L., B.M.J.U.) and Department of Medical Oncology (A.J.M.v.d.E.), VU University Medical Centre; Department of Neurology (E.L.J.H.), St. Antonius Hospital Utrecht; Department of Neurology (J.v.E.), Jeroen Bos
  • Mostert JP; From the Department of Neurology, Amsterdam Neuroscience, VUmc MS Centre Amsterdam (J.K., C.E.L., B.M.J.U.) and Department of Medical Oncology (A.J.M.v.d.E.), VU University Medical Centre; Department of Neurology (E.L.J.H.), St. Antonius Hospital Utrecht; Department of Neurology (J.v.E.), Jeroen Bos
  • van den Eertwegh AJM; From the Department of Neurology, Amsterdam Neuroscience, VUmc MS Centre Amsterdam (J.K., C.E.L., B.M.J.U.) and Department of Medical Oncology (A.J.M.v.d.E.), VU University Medical Centre; Department of Neurology (E.L.J.H.), St. Antonius Hospital Utrecht; Department of Neurology (J.v.E.), Jeroen Bos
  • Uitdehaag BMJ; From the Department of Neurology, Amsterdam Neuroscience, VUmc MS Centre Amsterdam (J.K., C.E.L., B.M.J.U.) and Department of Medical Oncology (A.J.M.v.d.E.), VU University Medical Centre; Department of Neurology (E.L.J.H.), St. Antonius Hospital Utrecht; Department of Neurology (J.v.E.), Jeroen Bos
Neurology ; 89(9): 970-972, 2017 08 29.
Article in En | MEDLINE | ID: mdl-28768850
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fingolimod Hydrochloride / Immunosuppressive Agents / Melanoma / Multiple Sclerosis Type of study: Diagnostic_studies Limits: Adult / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Neurology Year: 2017 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fingolimod Hydrochloride / Immunosuppressive Agents / Melanoma / Multiple Sclerosis Type of study: Diagnostic_studies Limits: Adult / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Neurology Year: 2017 Document type: Article Country of publication: